GURUFOCUS.COM » STOCK LIST » Utilities » Utilities - Independent Power Producers » Orion Pharma Ltd (DHA:ORIONPHARM) » Definitions » Cyclically Adjusted Revenue per Share

Orion Pharma (DHA:ORIONPHARM) Cyclically Adjusted Revenue per Share : BDT50.39 (As of Dec. 2024)


View and export this data going back to 2013. Start your Free Trial

What is Orion Pharma Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Orion Pharma's adjusted revenue per share for the three months ended in Dec. 2024 was BDT3.677. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is BDT50.39 for the trailing ten years ended in Dec. 2024.

During the past 12 months, Orion Pharma's average Cyclically Adjusted Revenue Growth Rate was -3.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

As of today (2025-05-04), Orion Pharma's current stock price is BDT27.20. Orion Pharma's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2024 was BDT50.39. Orion Pharma's Cyclically Adjusted PS Ratio of today is 0.54.

During the past 12 years, the highest Cyclically Adjusted PS Ratio of Orion Pharma was 1.62. The lowest was 0.56. And the median was 1.37.


Orion Pharma Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Orion Pharma's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Orion Pharma Cyclically Adjusted Revenue per Share Chart

Orion Pharma Annual Data
Trend Dec14 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 52.55 52.33

Orion Pharma Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 52.44 52.42 52.33 51.85 50.39

Competitive Comparison of Orion Pharma's Cyclically Adjusted Revenue per Share

For the Utilities - Independent Power Producers subindustry, Orion Pharma's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Orion Pharma's Cyclically Adjusted PS Ratio Distribution in the Utilities - Independent Power Producers Industry

For the Utilities - Independent Power Producers industry and Utilities sector, Orion Pharma's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Orion Pharma's Cyclically Adjusted PS Ratio falls into.


;
;

Orion Pharma Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Orion Pharma's adjusted Revenue per Share data for the three months ended in Dec. 2024 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=3.677/133.1571*133.1571
=3.677

Current CPI (Dec. 2024) = 133.1571.

Orion Pharma Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201409 12.553 100.428 16.644
201412 9.188 99.070 12.349
201503 11.143 99.621 14.894
201506 12.371 100.684 16.361
201509 11.812 100.392 15.667
201606 0.000 101.688 0.000
201609 11.194 101.861 14.633
201612 8.255 101.863 10.791
201703 9.857 102.862 12.760
201706 11.438 103.349 14.737
201709 12.214 104.136 15.618
201712 9.589 104.011 12.276
201803 10.892 105.290 13.775
201806 11.843 106.317 14.833
201809 15.297 106.507 19.125
201812 8.127 105.998 10.209
201903 5.263 107.251 6.534
201906 8.510 108.070 10.486
201909 9.515 108.329 11.696
201912 6.568 108.420 8.067
202003 6.212 108.902 7.596
202006 10.387 108.767 12.716
202009 12.517 109.815 15.178
202012 10.234 109.897 12.400
202103 10.421 111.754 12.417
202106 13.121 114.631 15.241
202109 5.076 115.734 5.840
202112 3.224 117.630 3.650
202203 4.863 121.301 5.338
202206 28.127 125.017 29.958
202209 16.729 125.227 17.788
202212 17.088 125.222 18.171
202303 9.819 127.348 10.267
202306 15.879 128.729 16.425
202309 15.426 129.860 15.818
202312 9.126 129.419 9.390
202403 8.698 131.776 8.789
202406 12.138 132.554 12.193
202409 7.037 133.029 7.044
202412 3.677 133.157 3.677

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Orion Pharma  (DHA:ORIONPHARM) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Orion Pharma's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=27.20/50.39
=0.54

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 12 years, the highest Cyclically Adjusted PS Ratio of Orion Pharma was 1.62. The lowest was 0.56. And the median was 1.37.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Orion Pharma Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Orion Pharma's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Orion Pharma Business Description

Traded in Other Exchanges
N/A
Address
153-154 Tejgaon Industrial Area, Orion House, Dhaka, BGD, 1208
Orion Pharma Ltd is a pharmaceutical company engaged in the manufacturing and marketing of pharmaceutical drugs and medicines. It provides its drugs in various dosage forms including tablet, capsule, syrup, suspension, injection, dry powder for syrup and suspension, for therapeutic groups like anticancer, antibiotics, antidiabetics, anxiolytics, diuretics, cardiovascular drugs, and others. In addition, the company is also involved in power generation activities. It generates maximum revenue from power generation activities. The group principally carries out its business operations and markets its products in Bangladesh.

Orion Pharma Headlines

No Headlines